Skip to content
VENTUREIP
Evidence review // live fund review

Invention,assessed.

Focus: what still has to be proven

Deep-tech ventures usually do not fail because the science is weak. They fail when a result that works in the lab cannot yet be made, sold, approved, or protected at company scale. VentureIP helps deep-tech VC funds see that gap before capital moves.

Founding access by review

Tier 3 at 1%

Redeem an access code or review the founding member access path before applying.

Scorecard model

Founding access

By review

Readiness profile

Problem4.0
Customer pull3.0
Ecosystem fit3.0
Buildability4.0
Business model2.5

Gap review

Production risk

Lab result

Early proof works

Pilot

Can it repeat?

Production

Yield, cost, approval

Patent coverage gap
Manufacturing yield
Approval or reimbursement path

1% founding carry rate

Available after review

Assessment snapshot

Built for fund teams reviewing hard science before capital moves.

Funds

Primary audience

Built for deep-tech investment teams

3

Core questions

Protection, scale, and proof

5 days

Review sprint

Five to eight ventures

3

Report outputs

Full report, IP brief, Cipher scorecard

Why this matters

The path from lab result to investment-ready evidence.

VentureIP shows fund teams what is strong, what is still an assumption, and what evidence needs to appear next.

Step 01

Proof gap

A working prototype is separated from evidence a fund can trust.

Step 02

Technical review

Patent strength, production risk, and next proof points are reviewed together.

Step 03

Decision package

The scorecard and analyst notes become a report the fund can use.

What VentureIP does

Three plain questions. One technical assessment.

Every engagement asks the same core questions: Is the invention meaningfully protected? Can the technology become a real product? What still has to be proven before capital moves? The venture judgment stays with the fund. Our job is the technical read that makes that judgment possible.

Pillar 01

Patent landscape

We review the patent the founder filed and the patents around it: competing filings, nearby inventions, and areas that may create conflict.

Pillar 02

Can the technology scale?

We compare what the prototype proves with what a real product would require: repeatable manufacturing, cost, supply chain, deployment, and approvals.

Pillar 03

Can the invention be protected?

We assess whether the patent position creates real leverage, or whether competitors can design around it quickly.

Core failure mode

The risk is the distance between a lab result and an investable company.

VentureIP turns that distance into a clear map: what is known, what is still assumed, and what has crossed the line into evidence a fund can act on.

Lab to production path

Technical review starts where the prototype stops.

Lab result

Early proof works

Pilot

Can it repeat?

Production

Yield, cost, approval

Patent coverage gap
Manufacturing yield
Approval or reimbursement path

The process

From invention disclosure to decision-ready report.

  1. Step 01

    Intake

    Invention disclosure, technical brief, and commercial context captured under NDA.

    Then
  2. Step 02

    Evidence review

    We check patents, technical literature, market context, regulation, and financial assumptions.

    Then
  3. Step 03

    Analyst review

    A domain analyst reviews every machine-generated finding before it enters the report.

    Then
  4. Step 04

    Three-format delivery

    Full report, technology and IP brief, and Cipher scorecard. Five business days for 5 to 8 ventures.

Cipher scorecard

Every assessment includes a Cipher validation score.

Five plain tests. One profile shape. A read on where the venture is strong and where the business gaps concentrate.

Signature output

The score is not the point. The shape is.

Cipher is VentureIP's scorecard for the distance between a credible technology and a company a fund can back. A venture can have strong science and still break on the path to market.

Founding cohort / By review

Apply to join the founding cohort.

Selection is by review, not first-come. Accepted funds receive Tier 3 access at the 1% founding carry rate.

Access pathBy review
ApplyReviewActivate

For funds investing in hard science

Apply to join the founding cohort.

Start with your current pipeline shape. Selection is by review, not first-come.